These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 22860699

  • 1. Efficacy of intranasal administration of a modified live feline herpesvirus 1 and feline calicivirus vaccine against disease caused by Bordetella bronchiseptica after experimental challenge.
    Bradley A, Kinyon J, Frana T, Bolte D, Hyatt DR, Lappin MR.
    J Vet Intern Med; 2012; 26(5):1121-5. PubMed ID: 22860699
    [Abstract] [Full Text] [Related]

  • 2. Effect of modified live or inactivated feline herpesvirus-1 parenteral vaccines on clinical and laboratory findings following viral challenge.
    Summers SC, Ruch-Gallie R, Hawley JR, Lappin MR.
    J Feline Med Surg; 2017 Aug; 19(8):824-830. PubMed ID: 27432436
    [Abstract] [Full Text] [Related]

  • 3. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus.
    Jas D, Aeberlé C, Lacombe V, Guiot AL, Poulet H.
    Vet J; 2009 Oct; 182(1):86-93. PubMed ID: 18694649
    [Abstract] [Full Text] [Related]

  • 4. Studies of the efficacy of a novel intranasal vaccine against feline bordetellosis.
    Williams J, Laris R, Gray AW, Jacobs AA.
    Vet Rec; 2002 Apr 06; 150(14):439-42. PubMed ID: 11993973
    [Abstract] [Full Text] [Related]

  • 5. Feline bordetellosis: challenge and vaccine studies.
    Jacobs AA, Chalmers WS, Pasman J, van Vugt F, Cuenen LH.
    Vet Rec; 1993 Sep 11; 133(11):260-3. PubMed ID: 8236648
    [Abstract] [Full Text] [Related]

  • 6. Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries.
    Helps CR, Lait P, Damhuis A, Björnehammar U, Bolta D, Brovida C, Chabanne L, Egberink H, Ferrand G, Fontbonne A, Pennisi MG, Gruffydd-Jones T, Gunn-Moore D, Hartmann K, Lutz H, Malandain E, Möstl K, Stengel C, Harbour DA, Graat EA.
    Vet Rec; 2005 May 21; 156(21):669-73. PubMed ID: 15908495
    [Abstract] [Full Text] [Related]

  • 7. Feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus antibody responses in seronegative specific pathogen-free cats after a single administration of two different modified live FVRCP vaccines.
    Lappin MR, Veir J, Hawley J.
    J Feline Med Surg; 2009 Feb 21; 11(2):159-62. PubMed ID: 18782676
    [Abstract] [Full Text] [Related]

  • 8. Feline panleukopenia virus, feline herpesvirus-1 and feline calicivirus antibody responses in seronegative specific pathogen-free kittens after parenteral administration of an inactivated FVRCP vaccine or a modified live FVRCP vaccine.
    Lappin MR.
    J Feline Med Surg; 2012 Feb 21; 14(2):161-4. PubMed ID: 22314095
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine.
    Scott FW, Geissinger CM.
    Am J Vet Res; 1999 May 21; 60(5):652-8. PubMed ID: 10328440
    [Abstract] [Full Text] [Related]

  • 14. Effects of a single dose of an intranasal feline herpesvirus 1, calicivirus, and panleukopenia vaccine on clinical signs and virus shedding after challenge with virulent feline herpesvirus 1.
    Lappin MR, Sebring RW, Porter M, Radecki SJ, Veir J.
    J Feline Med Surg; 2006 Jun 21; 8(3):158-63. PubMed ID: 16442823
    [Abstract] [Full Text] [Related]

  • 15. Use of serologic tests to predict resistance to feline herpesvirus 1, feline calicivirus, and feline parvovirus infection in cats.
    Lappin MR, Andrews J, Simpson D, Jensen WA.
    J Am Vet Med Assoc; 2002 Jan 01; 220(1):38-42. PubMed ID: 12680445
    [Abstract] [Full Text] [Related]

  • 16. Characterization of an avirulent FCV strain with a broad serum cross-neutralization profile and protection against challenge of a highly virulent vs feline calicivirus.
    Rong S, Lowery D, Floyd-Hawkins K, King V.
    Virus Res; 2014 Aug 08; 188():60-7. PubMed ID: 24685673
    [Abstract] [Full Text] [Related]

  • 17. Effect of vaccination on experimental infection with Bordetella bronchiseptica in dogs.
    Ellis JA, Haines DM, West KH, Burr JH, Dayton A, Townsend HG, Kanara EW, Konoby C, Crichlow A, Martin K, Headrick G.
    J Am Vet Med Assoc; 2001 Feb 01; 218(3):367-75. PubMed ID: 11201562
    [Abstract] [Full Text] [Related]

  • 18. A doggy tale: Risk of zoonotic infection with Bordetella bronchiseptica for cystic fibrosis (CF) patients from live licenced bacterial veterinary vaccines for cats and dogs.
    Moore JE, Rendall JC, Millar BC.
    J Clin Pharm Ther; 2022 Feb 01; 47(2):139-145. PubMed ID: 34328230
    [Abstract] [Full Text] [Related]

  • 19. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2.
    Jacobs AA, Bergman JG, Theelen RP, Jaspers R, Helps JM, Horspool LJ, Paul G.
    Vet Rec; 2007 Jan 13; 160(2):41-5. PubMed ID: 17220520
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.